NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients With Rheumatoid Arthritis

NCT04721808

CompletedN/A

Sponsor: Pfizer

Conditions: Arthritis, Rheumatoid

Countries: United States

This study is to investigate and describe the treatment patterns and effect of tofacitinib indicators for patients with Rheumatoid Arthritis (RA) assessing real world patient data entered in the Corrona RA Registry on or after November 2012

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Enrolled in the Corrona RA Registry and initiated tofacitinib on or after November 2012
* Initiate tofacitinib (defined as first ever use of tofacitinib) at the Corrona enrollment visit or at a Corrona follow-up visit from November 2012 onward.
* Have CDAI measured at baseline
* Have at least a 6-month follow-up visit and CDAI measured at the 6-month follow-up visit

Exclusion Criteria:

* There are no exclusion criteria for this study

Locations (1)

New York, New York, United States